Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,124.98 USD | -0.81% | +4.99% | +6.12% |
Jan. 21 | BofA Adjusts Price Target on ServiceNow to $1,280 From $1,075, Keeps Buy Rating | MT |
Jan. 21 | BNP Paribas Exane Adjusts ServiceNow Price Target to $975 From $867 | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.46B | 4.52B | 5.9B | 7.24B | 8.97B | |||||
Total Revenues | 3.46B | 4.52B | 5.9B | 7.24B | 8.97B | |||||
Cost of Goods Sold, Total | 797M | 987M | 1.35B | 1.57B | 1.92B | |||||
Gross Profit | 2.66B | 3.53B | 4.54B | 5.67B | 7.05B | |||||
Selling General & Admin Expenses, Total | 1.87B | 2.31B | 2.89B | 3.55B | 4.16B | |||||
R&D Expenses | 748M | 1.02B | 1.4B | 1.77B | 2.12B | |||||
Other Operating Expenses, Total | 2.62B | 3.33B | 4.29B | 5.32B | 6.29B | |||||
Operating Income | 42.12M | 199M | 257M | 355M | 762M | |||||
Interest Expense, Total | -33.28M | -32.75M | -28M | -27M | -24M | |||||
Interest And Investment Income | 55.41M | 39.48M | 20M | 82M | 302M | |||||
Net Interest Expenses | 22.13M | 6.74M | -8M | 55M | 278M | |||||
Currency Exchange Gains (Loss) | -594K | -14.08M | - | - | - | |||||
Other Non Operating Income (Expenses) | 3.53M | 4.28M | 3M | -11M | -32M | |||||
EBT, Excl. Unusual Items | 67.18M | 196M | 252M | 399M | 1.01B | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | -46.61M | -3M | - | - | |||||
EBT, Incl. Unusual Items | 67.18M | 149M | 249M | 399M | 1.01B | |||||
Income Tax Expense | -560M | 30.68M | 19M | 74M | -723M | |||||
Earnings From Continuing Operations | 627M | 119M | 230M | 325M | 1.73B | |||||
Net Income to Company | 627M | 119M | 230M | 325M | 1.73B | |||||
Net Income - (IS) | 627M | 119M | 230M | 325M | 1.73B | |||||
Net Income to Common Incl Extra Items | 627M | 119M | 230M | 325M | 1.73B | |||||
Net Income to Common Excl. Extra Items | 627M | 119M | 230M | 325M | 1.73B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.36 | 0.61 | 1.16 | 1.61 | 8.48 | |||||
Basic EPS - Continuing Operations | 3.36 | 0.61 | 1.16 | 1.61 | 8.48 | |||||
Basic Weighted Average Shares Outstanding | 186M | 193M | 198M | 201M | 204M | |||||
Net EPS - Diluted | 3.18 | 0.59 | 1.13 | 1.6 | 8.42 | |||||
Diluted EPS - Continuing Operations | 3.18 | 0.59 | 1.13 | 1.6 | 8.42 | |||||
Diluted Weighted Average Shares Outstanding | 197M | 202M | 203M | 204M | 206M | |||||
Normalized Basic EPS | 0.23 | 0.63 | 0.8 | 1.24 | 3.09 | |||||
Normalized Diluted EPS | 0.21 | 0.6 | 0.78 | 1.23 | 3.06 | |||||
American Depositary Receipts Ratio (ADR) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |||||
Supplemental Items | ||||||||||
EBITDA | 294M | 535M | 729M | 788M | 1.32B | |||||
EBITA | 76.72M | 245M | 333M | 436M | 847M | |||||
EBIT | 42.12M | 199M | 257M | 355M | 762M | |||||
EBITDAR | 358M | 618M | 829M | 900M | 1.45B | |||||
Total Revenues (As Reported) | 3.46B | 4.52B | 5.9B | 7.24B | 8.97B | |||||
Effective Tax Rate - (Ratio) | -832.79 | 20.57 | 7.63 | 18.55 | -71.73 | |||||
Current Domestic Taxes | 595K | 285K | 1M | 13M | 33M | |||||
Current Foreign Taxes | 15.66M | 53.06M | 52M | 46M | 101M | |||||
Total Current Taxes | 16.25M | 53.34M | 53M | 59M | 134M | |||||
Deferred Domestic Taxes | -4.36M | -6.4M | -6M | -2M | -885M | |||||
Deferred Foreign Taxes | -571M | -16.26M | -28M | 17M | 28M | |||||
Total Deferred Taxes | -576M | -22.66M | -34M | 15M | -857M | |||||
Normalized Net Income | 41.99M | 122M | 158M | 249M | 630M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 115M | 172M | 198M | 201M | 221M | |||||
Selling and Marketing Expenses | 1.53B | 1.86B | 2.29B | 2.81B | 3.3B | |||||
General and Administrative Expenses | 339M | 454M | 597M | 735M | 863M | |||||
Research And Development Expense From Footnotes | 748M | 1.02B | 1.4B | 1.77B | 2.12B | |||||
Net Rental Expense, Total | 64.2M | 83M | 100M | 112M | 129M | |||||
Imputed Operating Lease Interest Expense | 19.07M | 13.31M | 10.3M | 10.88M | 10.97M | |||||
Imputed Operating Lease Depreciation | 45.13M | 69.69M | 89.7M | 101M | 118M | |||||
Stock-Based Comp., COGS (Total) | 116M | 150M | 187M | 224M | 254M | |||||
Stock-Based Comp., R&D Exp. (Total) | 195M | 282M | 395M | 495M | 579M | |||||
Stock-Based Comp., S&M Exp. (Total) | 268M | 320M | 389M | 459M | 505M | |||||
Stock-Based Comp., G&A Exp. (Total) | 83.12M | 118M | 160M | 223M | 266M | |||||
Total Stock-Based Compensation | 662M | 870M | 1.13B | 1.4B | 1.6B |